Exelon Q2 2024 Adj. EPS $0.47 Beats $0.40 Estimate, Sales $5.361B Beat $4.897B Estimate
Portfolio Pulse from Benzinga Newsdesk
Exelon (NASDAQ:EXC) reported Q2 2024 adjusted EPS of $0.47, beating the $0.40 estimate by 17.5%. Sales were $5.361 billion, surpassing the $4.897 billion estimate by 9.47%, and up 11.27% from last year's $4.818 billion.
August 01, 2024 | 10:52 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Exelon (NASDAQ:EXC) reported strong Q2 2024 results with EPS of $0.47 beating estimates by 17.5% and sales of $5.361 billion exceeding expectations by 9.47%. Sales also increased by 11.27% year-over-year.
Exelon's strong earnings and revenue performance, significantly beating analyst estimates, is likely to positively impact its stock price in the short term. The year-over-year sales growth further supports a positive outlook.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100